Generic Anti-Cancer Injectables Market to Reach USD 15.4 Billion by 2034 | CAGR 5.2%
According to a newly published market research report by 24LifeSciences, global generic anti-cancer injectables market was valued at USD 9.8 billion in 2025 and is projected to reach USD 15.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 20262034. Generic anti-cancer injectables are bioequivalent versions of branded oncology drugs...
0 Commenti 0 Condivisioni 43 Visualizzazioni